These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2010-020492-23||Pharmacokinetics of ertapenem in a three-weekly dosing regime in patients with end stage renal disease depending on hemodialysis||not-yet-due|
|Ongoing||2013-001948-60||Effects of high and low dose vitamin D on postprandial leukocyte activation, oxidative stress and vascular function in healthy overweight and obese females||not-yet-due|
|Ongoing||2016-001213-24||Infection prevention and immune modulation by bacterial lysates: gaining insight into the mechanism of an old therapy in patients with asthma||not-yet-due|
|Ongoing||2016-001417-24||POSTPRANDIAL LIPEMIA, INFLAMMATION, AND VASCULAR FUNCTION IN DIABETES MODULATED BY SGLT2 INHIBITION||not-yet-due|
|Ongoing||2016-003253-15||MODULATION OF POSTPRANDIAL LIPEMIA, INFLAMMATION, AND VASCULAR FUNCTION BY PCSK9 INHIBITION IN DIABETES.||not-yet-due|
|Ongoing||2018-001380-23||The effect of tamsulosin on the spontaneous passage of bile stones||not-yet-due|